Back to Search
Start Over
Ceftolozane/tazobactam: Literature review of its activity on Taiwanese isolates before its launch in Taiwan (2012–2021)
- Source :
- Heliyon, Vol 10, Iss 13, Pp e33114- (2024)
- Publication Year :
- 2024
- Publisher :
- Elsevier, 2024.
-
Abstract
- Ceftolozane, a novel cephalosporin, combined with tazobactam, a known β-lactamase inhibitor, shows robust antipseudomonal activity, although it doesn't cover carbapenemases. Our review of data from 2012 to 2021 in Taiwan highlights TOL/TAZ's in-vitro performance.TOL/TAZ is most effective against Pseudomonas aeruginosa (91.3–94.4 % susceptible, with an MIC
Details
- Language :
- English
- ISSN :
- 24058440
- Volume :
- 10
- Issue :
- 13
- Database :
- Directory of Open Access Journals
- Journal :
- Heliyon
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.047ae70b731e4b9681647a6ba57ad645
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.heliyon.2024.e33114